However, the predictive value of combined detection of Sortilin, HMGB1, and GALP for assessing GDM risk in PCOS patients remains unclear, and the synergistic mechanisms underlying their roles in the progression from PCOS to GDM have not been systematically investigated. Here, HMGB1 is linked to polycystic ovary syndrome.